Sanofi

Sanofi is a top pharmaceutical company based in Paris, France

Sanofi is a top pharmaceutical company based in Paris, France.The company was founded in 1973, although it can source its origins back to 1718 when a family of pharmacists founded Laboratoires Midy

Sanofi is engaged in the discovery, development, manufacture and sale of pharmaceutical and biotechnology products worldwide.

Report: Partnering Deals and Alliances with Sanofi

Sanofi is a top pharmaceutical company based in Paris, France.

The company was founded in 1973, although it can source its origins back to 1718 when a family of pharmacists founded Laboratoires Midy

Sanofi is engaged in the discovery, development, manufacture and sale of pharmaceutical and biotechnology products worldwide.

The company has seven core components to its business:

  • Diabetes solutions – committed to improving global diabetes management through its integrated offering of treatments and medical devices
  • Human vaccines – provides patients with one of the world’s largest ranges of vaccines for the prevention and treatment of diseases
  • Innovative drugs – focused on providing answers for patients in a number of pathologies, including in particular the prevention and treatment of cancer, multiple sclerosis, thrombosis and cardiovascular diseases
  • Consumer healthcare – accelerating growth in consumer healthcare also involves regional development hubs in the US, Europe, Asia-Pacific and Latin America
  • Emerging markets – taking the best of Sanofi into markets in Asia, Latin America, Africa and the Middle East
  • Animal health –represented by Merial, is dedicated to the research, development, manufacture and commercialization of innovative pharmaceutical products and vaccines for animals. Its products are used by veterinarians, stock breeders, poultry producers and pet owners
  • Genzyme – our rare disease business is focused on products for the treatment of rare genetic diseases and other chronic debilitating diseases, including Lysosomal Storage Disorders, or LSDs, a group of metabolic disorders caused by enzyme deficiencies

Sanofi has an active partnering group that recognizes the significant role played by 3rd party collaborations in delivering great opportunities. Sanofi has a long history of partnering, building numerous collaborative partnerships more

Sanofi announced over 274 partnering / licensing deals since 2005, with over 33 deals in 2012 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in infectives, oncology, immunology, central nervous system, metabolic and cardiovascular diseases more

Sanofi has also announced 23 M&A deals since 2005, with the lead deals being the acquisition of Genzyme, Zentiva and Chattem more

Report: Partnering Deals and Alliances with Sanofi

Examples of recent partnering and licensing deals announced by Sanofi can be viewed in Current Partnering's Sanofi partnering activity review article.

Examples of recent M&A deals announced by Sanofi can be viewed in Current Partnering's Sanofi M&A activity review article.

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Sanofi

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Sanofi

Report: Partnering Deals and Alliances with Big Pharma

 

Available resources for deal coverage for Sanofi

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Sanofi company profile, recent partnering, M&A and financing news and articles

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Print Friendly, PDF & Email